TCL Archive FDA approves a new cancer drug, Vidaza, and two sNDAs, without going to ODAC. A date with ODAC may signal a weak case for drug approval, recent approval data indicate. May 28, 2004
TCL Archive House Bill Gives NCI $135 Million Increase, NIH $846 Million for FY 1988 Over 1987 Budgets August 7, 1987
TCL Archive NCS Group Asks DRG Adjustments For Institutions With Peer reviewed Components, 25 Protocol Patients July 1, 1983
